Dual gip/GLP-1 receptor agonists

4 papers3 findings

Outcomes

2

Body weight

downin humans1downin reviews1

2 studies

Dual gip/GLP-1 receptor agonists decrease body weight.
Reviewin obesity
Advances in the management of obesity: non-pharmacological strategies, herbal formulations, current pharmacotherapy, emerging drugs, and future perspectives
Frontiers in endocrinology7 Sep 2026
Dual gip/GLP-1 receptor agonists decrease body weight in humans.
Reviewin comorbid obesity and OSA
Sleep and obesity-known interactions and open questions
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine3 Aug 2026

Obstructive sleep apnea

downin humans1

1 study

Dual gip/GLP-1 receptor agonists decrease obstructive sleep apnea in humans.
Reviewin comorbid obesity and OSA
Sleep and obesity-known interactions and open questions
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine3 Aug 2026

More on Obstructive sleep apnea

Latest

4 in 12 months

Frontiers in Endocrinology22 Sep

Advances in the management of obesity: non-pharmacological strategies, herbal formulations, current pharmacotherapy, emerging drugs, and future perspectives

Cardiovascular & Hematological Disorders Drug Targets24 Aug

Venous Congestion in Metabolic Heart Disease: Potential Indirect Role of Dual Incretin Agonists

ReviewGLP-1 receptor agonists

Zhonghua Yi Xue Za Zhi19 Aug

Expert consensus on the clinical application of nutrient-stimulated hormone receptor agonist in the treatment of type 2 diabetes mellitus (2026 edition)

CommentaryGLP-1 receptor agonists

Journal of Clinical Sleep Medicine4 Aug

Sleep and obesity-known interactions and open questions